Paris, France, January 20, 2022 – For the second year in a row, the Servier Group has obtained Top Employer certification in six countries where it operates: Belgium, Spain, France, Greece, Italy and Portugal. Thanks to these regional certifications, Servier has obtained the Top Employer Europe 2022 certification.
Awarded by the Top Employers Institute, the certification recognizes the excellence of Servier’s HR practices and contributes to strengthening its employer brand and reputation among employees and candidates.
“Being certified Top Employer Europe 2022 for the second consecutive year is a tangible acknowledgement of the high standard of our HR practices, which support our talent attraction and retention policies. It is a distinction that we are proud of, especially given the sanitary context where the working conditions remain challenging. We are thus encouraged to maintain this dynamic of continuous improvement and a close relationship with employees,” says Nicolas Bouts, Executive Vice President of Human Resources for the Servier Group.
Employee engagement: an essential lever for the success of the Group’s transformation
Servier in France has been particularly successful in implementing HR practices that promote employee engagement and well-being, with an overall score of 84.16%, up 3 points from last year.
Over the past year, Servier has been committed to the well-being of its employees and focused on creating a favorable work environment: medical prevention programs were organized, measures to facilitate the work/life balance were rolled out, and the home office policy was reinforced. Servier also deployed digital solutions to further improve the work environment and respond to the new hybrid working methods.
Finally, at the Group level, the Servier Leadership Model based on the company’s values was deployed to all 21,800 employees in 2021 giving each employee the means to commit to building the future of the company together.
David Plink, CEO of the Top Employers Institute, said: “Reflecting on the demanding year that has, like the year before it, impacted organizations across the world, Servier has continued to show that it prioritizes maintaining excellent people practices. In the past year Servier continued to meet the challenges of the wider world of work while working determinedly to positively impact the lives of their workforce.”
A certification in addition to the 41 HR labels obtained in 2021
Servier is recognized as an employer of choice, as demonstrated by the 41 labels and awards, including 17 Great Place to Work certifications, obtained in 2021 by its various subsidiaries. These awards reflect the attention the Group pays to its employees’ well-being and its desire to support them through innovative HR practices.
This certification, awarded by the Top Employers Institute, an international organization created 30 years ago, evaluates the excellence of Human Resources (HR) practices. It allows participating organizations to be validated, certified and recognized as an employer of choice.
The Top Employers Institute program certifies companies based on their participation and results in the HR Best Practices Survey. This survey covers six major HR areas, divided into twenty themes such as talent management strategy, work environment, recruitment of new employees, training and skills development, well-being at work, and diversity and inclusion.
Servier is a global pharmaceutical group governed by a Foundation. With a strong international presence in 150 countries and a total revenue of 4.7 billion euros in 2021, Servier employs 21,800 people worldwide. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. It also integrates the patient’s voice at the heart of its activities.
A leader in cardiology, the ambition of the Servier Group is to become a renowned and innovative player in oncology. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology, neuroscience and immuno-inflammatory diseases. To promote access to healthcare for all, the Servier Group also offers a range of quality generic drugs covering most pathologies. More information: servier.com.